WASHINGTON, D.C. (Reuters) — Two leading U.S. grain groups have asked Syngenta AG to suspend the commercialization in the United States of two genetically modified strains of corn not approved in China.
The National Grain and Feed Association and the North American Export Grain Association wrote to Syngenta, asking it to hold back on its Agrisure Viptera and Duracade corn varieties until China and other U.S. export markets have granted regulatory approval.
“Numerous negative consequences” follow when export markets are put at risk through commercialization of GM seeds before import approvals are obtained, the groups said.
Read Also
Saskatchewan throne speech promises strong economy
Saskatchewan’s legislative agenda for the coming year will focus on meeting the challenges of new world trading relationships, said the speech from the throne.
Multiple cargoes of U.S. corn, totalling 600,000 tonnes, have been rejected by Chinese authorities since November because they contained the Agrisure Viptera variety, known as MIR 162, which has been awaiting Beijing’s acceptance for more than two years.
“NAEGA and NGFA are gravely concerned about the serious economic harm to exporters, grain handlers and, ultimately, agricultural producers … that has resulted from Syngenta’s current approach to stewardship of Viptera,” the groups said.
The intended product launch of Duracade “risks repeating and ex-tending the damage. Immediate action is required by Syngenta to halt such damage,” the associations said.
They also urged U.S. farmers to “evaluate these issues” when preparing to plant corn this year.
Syngenta recently said its Agrisure Duracade variety will be available for planting for the first time this year in “limited quantities” after U.S. authorities cleared it for sale and cultivation last year.
